Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...

Amlodipine besylate Tablets USP 5 mg, Ranitidine Tablets USP 150 mg, Ranitidine Tablets USP 300 mg, Ciprofloxacin Tablets USP 250 mg, Ciprofloxacin Tablets USP 500 mg, Atorvastatin Tablets USP ...

In September 2008, the company received the US Food and Drug Administration approval for anti-hypertension drug amlodipine besylate tablets in multiple strengths and in November 2008, their ...

Cipla rolls out mobile application for asthma screening India has a three-fold higher mortality rate and two-fold higher asthma-associated disability burden compared to the global proportion. PTI ...

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active ...

Quadrant Future Tek's IPO opens for subscription on January 7. The company aims to raise Rs 290 crore through a fresh issue. Proceeds will be used for working capital, capital expenditure, and debt ...

The Quarterly Results page of Cipla Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.